CRISPR Takes the Front Seat in CART-Cell Development.
- Published in:
- BioDrugs, 2021, v. 35, n. 2, p. 113, doi. 10.1007/s40259-021-00473-y
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2021 AND VI 35 AND IP 2
Results: 4
1
2
Clinical Development of New Antibody–Drug Conjugates in Breast Cancer: To Infinity and Beyond.
- Published in:
- BioDrugs, 2021, v. 35, n. 2, p. 159, doi. 10.1007/s40259-021-00472-z
- By:
- Publication type:
- Article
3
Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists.
- Published in:
- BioDrugs, 2021, v. 35, n. 2, p. 187, doi. 10.1007/s40259-020-00464-5
- By:
- Publication type:
- Article
4
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review.
- Published in:
- BioDrugs, 2021, v. 35, n. 2, p. 175, doi. 10.1007/s40259-021-00467-w
- By:
- Publication type:
- Article